EVALUATION OF ATHEROGENIC PLASMA INDEX IN RELATION TO CLINICAL, SUBCLINICAL FEATURES IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE

Văn Sơn Nguyễn1,, Đức Hùng Trần1, Thị Thanh Diễm Nguyễn1, Vũ Thu Hà Phạm 1, Đức Minh Phạm 1, Thị Huế Phạm 1
1 103 Military Hospital, Vietnam Military Medical Academy

Main Article Content

Abstract

Objectives: To assessment of Atherogenic Plasma Index (AIP) in relation to clinical, subclinical features in stable ischemic heart disease (IHD). Patients and methods: 50 patients with stable IHD and 30 individuals underwent calculated according to the formula based on test results. Results: At baselines, the mean age of group stable IHD was 67.30 ± 10.48 and the group non – IHD was 64.7 ± 10.08. The median value of AIP in group stable IHD was 0,34 (0,11 - 0,51) higher than control group 0,18 (-0,43 - 0,37) with p > 0,05, respectively. Median of VAI of males 0,33 (0,11 - 0,51) was lower than females 0,35 (0,1 - 0,6), non – significant p > 0,05. In participants with and without diabetes, there was statistically significant different in VAI between groups, p < 0.05 but not in smoking, hypertension and dyslipidemia. No significant differences were observed among patients levels of chest pain by Canadian coronary score (CCS) and between two groups of heart failure (HF) and non – HF. Conclusion: In conclusion, AIP index showed no difference between the two groups. AIP is only observed associated with diabetes or non-diabetic status. There was no relation with age, sex and other cardiovascular risk factors including smoking, hypertension and dyslipidemia as well as chest pain or heart failure has not been established.

Article Details

References

1. Bộ Y tế, Thực hành chẩn đoán và điều trị bệnh động mạch vành 2020: p. tr. 54
2. Nguyễn Thanh Xuân, Nghiên cứu mối liên quan giữa mức độ tổn thương động mạch vành với một số yếu tố nguy cơ tim mạch. Tạp chí y -dược học quân sự, 2014. Số 1-2014.
3. Phạm Vũ Thu Hà, “Nghiên cứu sự biến đổi chỉ số tương hợp thất trái – động mạch ở người mắc bệnh tim thiếu máu cục bộ mạn tính trước và sau can thiệp động mạch vành qua da” Luận án tiến sĩ y học, 2021.
4. Calabrò, P., et al., Epidemiology and Management of Patients With Acute Coronary Syndromes in Contemporary Real-World Practice: Evolving Trends From the EYESHOT Study to the START-ANTIPLATELET Registry. Angiology, 2018. 69(9): p. 795-802.
5. Hamzeh, B., et al., Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran. Lipids Health Dis, 2021. 20(1): p. 82.
6. Mahalle, N., et al., Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease. Indian J Endocrinol Metab, 2014. 18(1): p. 48-55.
7. Mahalle, N., et al., Association of metabolic syndrome with severity of coronary artery disease. Indian J Endocrinol Metab, 2014. 18(5): p. 708-14.
8. Zheng, Y., et al., Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China. Cardiovasc Diabetol, 2022. 21(1): p. 29.